November 28, 2015
Recommended Topic Related To:

Humulin N

"The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.

Diabetic retinopathy (DR) is the most common diabetic eye disease"...

Humulin N



Excess insulin administration may cause hypoglycemia and hypokalemia [see WARNINGS AND PRECAUTIONS]. Mild episodes of hypoglycemia can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or physical activity level may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with intramuscular/subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately.


HUMULIN N is contraindicated:

  • During episodes of hypoglycemia [see WARNINGS AND PRECAUTIONS], and
  • In patients who have had hypersensitivity reactions to HUMULIN N or any of its excipients [see WARNINGS AND PRECAUTIONS].
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 1/27/2014


Humulin N - User Reviews

Humulin N User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Humulin N sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Find tips and advances in treatment.